← Back to Search

Cancer Vaccine

Vaccine Therapy for Stage III Melanoma

Phase 3
Waitlist Available
Research Sponsored by CancerVax Corporation
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Must have Stage III melanoma
Must have had all clinically-detectable disease surgically removed
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 5 years
Awards & highlights

Study Summary

This trial is testing a vaccine to prevent melanoma from recurring after surgery to remove all of the cancer.

Who is the study for?
This trial is for patients with Stage III melanoma who have had their cancer surgically removed. Participants must not be on immune-compromising medications, including some corticosteroids and certain radiation therapies, nor can they have HIV or Hepatitis A, B, or C.Check my eligibility
What is being tested?
The study is testing the effectiveness of CancerVax™ vaccine in preventing or delaying the return of melanoma after surgical removal. It's a Phase 3 trial where the main focus is to see if this vaccine can help keep cancer from coming back.See study design
What are the potential side effects?
While specific side effects are not listed here, vaccines like CancerVax™ could potentially cause reactions at the injection site, flu-like symptoms, allergic responses, and may affect how your immune system works.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
My melanoma is at Stage III.
Select...
All visible signs of my disease have been surgically removed.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 5 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 5 years for reporting.

Treatment Details

Find a Location

Who is running the clinical trial?

CancerVax CorporationLead Sponsor
2 Previous Clinical Trials
670 Total Patients Enrolled
2 Trials studying Melanoma
670 Patients Enrolled for Melanoma

Media Library

CancerVax™ Vaccine (Cancer Vaccine) Clinical Trial Eligibility Overview. Trial Name: NCT00052130 — Phase 3
Melanoma Research Study Groups:
Melanoma Clinical Trial 2023: CancerVax™ Vaccine Highlights & Side Effects. Trial Name: NCT00052130 — Phase 3
CancerVax™ Vaccine (Cancer Vaccine) 2023 Treatment Timeline for Medical Study. Trial Name: NCT00052130 — Phase 3

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

How can I sign up to participate in this research study?

"Eligible participants for this study must be between 18-80 years old, have had all surgically removable cancer removed, not currently taking any medications which would inhibit their immune system, and cannot have received certain types of radiation therapy in the past."

Answered by AI

In how many different hospitals is this medical study being conducted today?

"So far, 55 patients have been recruited for this trial from locations such as Central Arkansas Veterans Healthcare System in Little Rock, Mt. Sinai Comprehensive Cancer Center in Miami, and Cedars Sinai Comprehensive Cancer Center in Los Angeles."

Answered by AI

Has this medication been given the okay by the Federal Drug Administration?

"This is a Phase 3 trial, so there is some data supporting efficacy and multiple rounds of data supporting safety. Consequently, our team at Power rates the safety of this treatment as being a 3 on a scale from 1 to 3."

Answered by AI

Does this study allow for elderly participants?

"This study's age restrictions are that patients must be 18 or older, and no more than 80 years old."

Answered by AI
Recent research and studies
clinicaltrials.govStudy
Vaccine Therapy for Patients With Stage III Melanoma
2024. "Vaccine Therapy for Patients With Stage III Melanoma". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT00052130.
~745 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top